XML 43 R35.htm IDEA: XBRL DOCUMENT v3.26.1
Stock Options, Restricted Stock and Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

Stock option activity is summarized as follows:

 

 

NUMBER OF
STOCK
OPTIONS

 

 

WEIGHTED-
AVERAGE
EXERCISE
PRICE

 

 

WEIGHTED-
AVERAGE
REMAINING
CONTRACTUAL
TERM (IN YEARS)

 

 

AGGREGATE
INTRINSIC
VALUE
(IN THOUSANDS)

 

Outstanding as of December 31, 2025

 

 

6,246,920

 

 

$

4.21

 

 

 

6.79

 

 

$

13,695

 

Granted

 

 

2,230,959

 

 

 

5.68

 

 

 

 

 

 

 

Exercised

 

 

(10,937

)

 

 

2.57

 

 

 

 

 

 

 

Cancelled, forfeited or expired

 

 

(23,797

)

 

 

6.49

 

 

 

 

 

 

 

Outstanding as of March 31, 2026

 

 

8,443,145

 

 

$

4.60

 

 

 

7.45

 

 

$

10,552

 

Exercisable as of March 31, 2026

 

 

4,353,779

 

 

$

3.18

 

 

 

5.72

 

 

$

9,708

 

Unvested as of March 31, 2026

 

 

4,089,366

 

 

$

6.11

 

 

 

9.29

 

 

$

844

 

Schedule of Fair Value of Stock Options Granted Was Estimated on Black-Scholes Options

The fair value of stock options granted was estimated on the grant date using the Black-Scholes option pricing model based on the following range of assumptions:

 

 

THREE MONTHS ENDED
MARCH 31,

 

 

 

2026

 

 

2025

 

Expected option life (years)

 

5.00 - 6.08

 

 

5.67 - 6.08

 

Risk-free interest rate

 

3.62% - 4.02%

 

 

4.03% - 4.52%

 

Expected volatility

 

117.24% - 120.71%

 

 

118.46% - 119.98%

 

Expected dividend yield

 

 

0

%

 

 

0

%

Summary of Restricted Stock Activity

A summary of the Company's performance stock unit (PSU) activity and related information is summarized as follows:

 

 

NUMBER OF
SHARES OPTIONS

 

 

WEIGHTED-
AVERAGE GRANT
DATE FAIR VALUE

 

Unvested at December 31, 2025

 

 

 

 

$

 

Granted

 

 

300,000

 

 

 

4.95

 

Vested

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Unvested at March 31, 2026

 

 

300,000

 

 

$

4.95

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense for the three months ended March 31, 2026 and 2025 was classified in the condensed consolidated statements of operations and comprehensive income (loss) as follows (in thousands):

 

 

 

THREE MONTHS ENDED
MARCH 31,

 

 

 

2026

 

 

2025

 

Research and development

 

$

604

 

 

$

(126

)

General and administrative

 

 

848

 

 

 

440

 

Total stock-based compensation expense

 

$

1,452

 

 

$

314